This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center

Charles Chase, PhD
Vice President, Pharmaceutical Development at Elicio Therapeutics

Agenda Sessions

  • ROOM 205B: Synthesis and Formulation of Amphiphile Modified mKRAS Peptides

    9:30am